Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Net Cash Flow (2022 - 2025)

CervoMed (CRVO) has disclosed Net Cash Flow for 9 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 195.71% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.4 million through Dec 2025, up 88.16% year-over-year, with the annual reading at -$764027.0 for FY2025, 163.32% down from the prior year.
  • Net Cash Flow hit -$1.2 million in Q4 2025 for CervoMed, down from $1.1 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $10.2 million in Q3 2022 to a low of -$42.8 million in Q2 2024.
  • Historically, Net Cash Flow has averaged -$3.9 million across 4 years, with a median of -$1.3 million in 2024.
  • Biggest five-year swings in Net Cash Flow: crashed 273.17% in 2024 and later soared 205.52% in 2025.
  • Year by year, Net Cash Flow stood at $6.3 million in 2022, then tumbled by 141.73% to -$2.6 million in 2023, then surged by 147.72% to $1.3 million in 2024, then plummeted by 195.71% to -$1.2 million in 2025.
  • Business Quant data shows Net Cash Flow for CRVO at -$1.2 million in Q4 2025, $1.1 million in Q3 2025, and -$6.8 million in Q2 2025.